Related Experiment Video

Updated: May 9, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Commentary on 'prophylactic drug management for febrile seizures in children'

Jeanette Robertson1

  • 1Child & Adolescent Health Service, Perth, WA, Australia. jeanette.robertson@health.wa.gov.au

Evidence-Based Child Health : a Cochrane Review Journal
|July 24, 2013
PubMed

Insights

This commentary discusses prophylactic drug management for febrile seizures in children, based on a Cochrane review. It evaluates the evidence for using medications to prevent recurrent febrile seizures in pediatric populations.

Area of Science:

  • Pediatric Neurology
  • Evidence-Based Medicine

Background:

  • Febrile seizures are common in young children.
  • Prophylactic medication is sometimes used to prevent recurrence.
  • The Cochrane review by Offringa and Newton (2012) systematically evaluated this topic.

Purpose of the Study:

  • To provide a commentary on the Cochrane review regarding prophylactic drug management for febrile seizures in children.
  • To critically appraise the findings and implications of the systematic review for clinical practice and future research.

Main Methods:

  • The commentary analyzes the methodology and results of the Cochrane systematic review.
  • It discusses the quality of evidence and the limitations identified in the original review.

Main Results:

  • The commentary highlights the findings of the Cochrane review concerning the efficacy and harms of prophylactic medications for febrile seizures.
  • It addresses the limited evidence supporting routine prophylactic treatment due to potential side effects and lack of proven long-term benefits.

Conclusions:

  • The commentary likely concludes that the evidence for prophylactic drug management of febrile seizures in children is weak.
  • It may suggest a cautious approach, emphasizing individualized treatment decisions based on seizure characteristics and parental concerns, rather than routine pharmacological intervention.

Keywords:
febrile seizuresprophyllaxis

More Related Videos

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Related Concept Videos

Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...